<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29941978</article-id>
<article-id pub-id-type="pmc">6372583</article-id>
<article-id pub-id-type="publisher-id">110</article-id>
<article-id pub-id-type="doi">10.1038/s41386-018-0110-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Peripubertal stress-induced heightened aggression: modulation of the glucocorticoid receptor in the central amygdala and normalization by mifepristone treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Papilloud</surname>
<given-names>Aurelie</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Veenit</surname>
<given-names>Vandana</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tzanoulinou</surname>
<given-names>Stamatina</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riccio</surname>
<given-names>Orbicia</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zanoletti</surname>
<given-names>Olivia</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guillot de Suduiraut</surname>
<given-names>Isabelle</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grosse</surname>
<given-names>Jocelyn</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7713-8321</contrib-id>
<name>
<surname>Sandi</surname>
<given-names>Carmen</given-names>
</name>
<address>
<phone>+41-21-693 9534</phone>
<email>carmen.sandi@epfl.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121839049</institution-id><institution-id institution-id-type="GRID">grid.5333.6</institution-id><institution>Laboratory of Behavioral Genetics, Brain Mind Institute, </institution><institution>Ecole Polytechnique Fédérale de Lausanne, </institution></institution-wrap>Lausanne, Switzerland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Present Address: Departement of Clinical Neuroscience, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 4988</institution-id><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution>Present Address: Departement of Basic Neurosciences, </institution><institution>University of Geneva, </institution></institution-wrap>1211 Geneva, Switzerland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<volume>44</volume>
<issue>4</issue>
<fpage>674</fpage>
<lpage>682</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>3</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© American College of Neuropsychopharmacology 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Despite the enormous negative impact of excessive aggression for individuals and societies, there is a paucity of treatments. Here, using a peripubertal stress model of heightened aggression in rats, we investigated the involvement of the glucocorticoid system and tested the effectiveness of antiglucocorticoid treatment to normalize behavior. We assessed peripubertal stress-induced changes in glucocorticoid (GR) and mineralocorticoid (MR) gene expression in different amygdala nuclei and hippocampus, and report a specific increase in GR mRNA expression in the central amygdala (CeA). Administration of mifepristone (10 mg/kg), a GR antagonist, before stressor exposure at peripuberty prevented the habituation of plasma corticosterone responses observed throughout the stress protocol. This treatment also prevented the increase in aggression and GR expression in the CeA observed in peripubertally stressed rats at adulthood. Viral downregulation of CeA GR expression at adulthood led to reduced aggression. Subsequently, we showed that a brief, 3-day, treatment with mifepristone at adulthood was effective to normalize the abnormal aggression phenotype in peripubertally stressed rats. Our results support a key role for GR actions during peripubertal stress for the long-term programming of heightened aggression. Strikingly, they also support the translational interest of testing the effectiveness of mifepristone treatment to diminish reactive aggression in early adversity-related human psychopathologies.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Stress and resilience</kwd>
<kwd>Emotion</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001711</institution-id>
<institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)</institution>
</institution-wrap>
</funding-source>
<award-id>31003A-152614</award-id>
<award-id>51NF40-158776</award-id>
<principal-award-recipient>
<name>
<surname>Sandi</surname>
<given-names>Carmen</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004966</institution-id>
<institution>EC | Fifth Framework Programme (European Union Fifth Framework Programme)</institution>
</institution-wrap>
</funding-source>
<award-id>603016</award-id>
<principal-award-recipient>
<name>
<surname>Sandi</surname>
<given-names>Carmen</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© American College of Neuropsychopharmacology 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>